| UHC UMR Medical and Drug | Evkeeza® (Evinacumab-Dgnb) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Gender Dysphoria Treatment – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Genetic Testing for Cardiac Disease – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Genetic Testing for Hereditary Cancer – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Home Traction Therapy – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Immune Globulin (IVIG and SCIG) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Leqembi® (Lecanemab-Irmb) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Lower Extremity Prosthetics – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Molecular Oncology Testing for Solid Tumor Cancer Diagnosis, Prognosis, and Treatment Decisions – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC UMR Medical and Drug | Obstructive and Central Sleep Apnea Treatment – Commercial and Individual Exchange Medical Policy | 2026-04-01 |